Detalhe da pesquisa
1.
Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Respir Res
; 20(1): 18, 2019 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30691468
2.
Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Respir Res
; 19(1): 224, 2018 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458866
3.
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
Respir Res
; 18(1): 19, 2017 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28100244
4.
Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.
Infection
; 44(1): 65-76, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26370552
5.
Previous outpatient antibiotic use in patients admitted to hospital for COPD exacerbations: room for improvement.
Infection
; 41(2): 361-70, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22907284
6.
Erratum to: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
Respir Res
; 18(1): 35, 2017 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28187787
7.
Usefulness of a patient symptom diary card in the monitoring of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Int J Clin Pract
; 66(7): 711-7, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22698424
8.
Symptom variability in patients with severe COPD: a pan-European cross-sectional study.
Eur Respir J
; 37(2): 264-72, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21115606
9.
The best on infections: update from the 2010 ERS Congress.
Eur Respir J
; 38(2): 450-5, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21436358
10.
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD.
Eur Respir J
; 36(1): 96-104, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19897551
11.
TB or not TB: update from the ERS Respiratory Infection Assembly 10.
Eur Respir J
; 36(3): 665-70, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20525720
12.
Laboratory testing of individuals with severe alpha1-antitrypsin deficiency in three European centres.
Eur Respir J
; 35(5): 960-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20436173
13.
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007.
Eur Respir J
; 36(4): 758-65, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19996189
14.
Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document.
Rev Esp Quimioter
; 33(1): 49-67, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31933347
15.
Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities.
Thorax
; 64(10): 863-8, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19553233
16.
Validation of the COPD severity score for use in primary care: the NEREA study.
Eur Respir J
; 33(3): 519-27, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19164354
17.
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD.
Eur Respir J
; 34(5): 1066-71, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19386683
18.
[The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary]. / Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España.
Arch Bronconeumol
; 45(1): 41-7, 2009 Jan.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19186298
19.
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia.
Int J Tuberc Lung Dis
; 23(10): 1100-1106, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31627775
20.
Outcomes for COPD pharmacological trials: from lung function to biomarkers.
Eur Respir J
; 31(2): 416-69, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18238951